Pressure Biosciences Inc Revenue Growth Rates (PBIO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pressure Biosciences Inc   (PBIO)
 

PBIO's Revenue Growth by Quarter and Year

Pressure Biosciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBIO Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.42
1st Quarter March 0.35
FY 0.77

PBIOs Annual Revenue
Pressure Biosciences Inc 's Revenue in the fiscal year 2023 $ 1.98 millions
Pressure Biosciences Inc 's Revenue in the fiscal year 2022 $ 1.73 millions
Pressure Biosciences Inc 's Revenue in the fiscal year 2021 $ 2.00 millions
Pressure Biosciences Inc 's Revenue in the fiscal year 2020 $ 1.22 millions
Pressure Biosciences Inc 's Revenue in the fiscal year 2019 $ 1.81 millions




PBIO Revenue second quarter 2024 Y/Y Growth Comment
Pressure Biosciences Inc reported decline in Revenue in the second quarter 2024 by -17.3% to $ 0.42 millions, from the same quarter in 2023.
The contraction in the second quarter 2024 Pressure Biosciences Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 12%.

Looking into second quarter 2024 results within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue growth. While Pressure Biosciences Inc ' s Revenue fall of -17.3% ranks overall at the positon no. 3646 in the second quarter 2024.


PBIO Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - -49.18 % 90.62 % 100 %
3rd Quarter September - 192.86 % -73.08 % -1.89 %
2nd Quarter June -17.3 % 2 % -18.03 % 125.93 %
1st Quarter March -52.7 % 54.17 % -14.29 % 124 %
FY   - 13.87 % -13.93 % -

Financial Statements
Pressure Biosciences Inc 's second quarter 2024 Revenue $ 0.42 millions PBIO's Income Statement
Pressure Biosciences Inc 's second quarter 2023 Revenue $ 0.51 millions Quarterly PBIO's Income Statement


PBIO Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - -24.39 % 335.71 % -38.46 %
3rd Quarter September - -19.61 % -72 % -14.75 %
2nd Quarter June 20.51 % -31.08 % 4.17 % 8.93 %
1st Quarter March 12.9 % 21.31 % 50 % 250 %
FY (Year on Year)   - 13.87 % -13.93 % -


Back to PBIO Growth rate Comparisons >> Back to PBIO Growth rate Comparisons >>


Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #544
Overall #3646

Revenue Y/Y Growth Statistics
High Average Low
186.74 % 12 % -72.21 %
(Dec 31 2023)   (Jun 30 2020)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #544
Overall #3646
Revenue Y/Y Growth Statistics
High Average Low
186.74 % 12 % -72.21 %
(Dec 31 2023)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Pressure Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
321.55 % 12.92 % -71.09 %
(Dec 31 2022)  


PBIO's II. Quarter Q/Q Revenue Comment
Pressure Biosciences Inc achieved in the II. Quarter 2024 above company average sequential Revenue jump of 20.51%, to $ 0.42 millions, from $0.35 millions in the first quarter.
PBIO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Pressure Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 580.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #153
Overall #580
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #153
Overall #580
Revenue Q/Q Growth Statistics
High Average Low
321.55 % 12.92 % -71.09 %
(Dec 31 2022)  


PBIO's II. Quarter Q/Q Revenue Comment
Pressure Biosciences Inc achieved in the II. Quarter 2024 above company average sequential Revenue jump of 20.51%, to $ 0.42 millions, from $0.35 millions in the first quarter.
PBIO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Pressure Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 580.


Pressure Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Revenue 12 Months Ending $ 1.50 $ 1.59 $ 1.98 $ 2.27 $ 2.00
Y / Y Revenue Growth (TTM) -25.31 % -20.28 % 14.36 % 58.11 % 10.59 %
Year on Year Revenue Growth Overall Ranking # 1642 # 2497 # 2966 # 2509 # 0
Seqeuential Revenue Change (TTM) -5.67 % -19.79 % -12.97 % 13.42 % 0.69 %
Seq. Revenue Growth (TTM) Overall Ranking # 842 # 555 # 2931 # 2658 # 0


Cumulative Revenue growth Comment
Pressure Biosciences Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -25.31% year on year, at Jun 30 2024 compare to the -20.28% decrease at Mar 31 2024. If the Pressure Biosciences Inc 's fiscal year would end at Jun 30 2024, annual Revenue would be $2 millions.

In the Healthcare sector 305 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1642, from total ranking in previous quarter at 2497.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 306
Overall # 1642

Revenue TTM Y/Y Growth Statistics
High Average Low
69.82 %
 7.49 %
-41.75 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 217
S&P 500 # 842
Cumulative Revenue growth Comment
Pressure Biosciences Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -25.31% year on year, at Jun 30 2024 compare to the -20.28% decrease at Mar 31 2024. If the Pressure Biosciences Inc 's fiscal year would end at Jun 30 2024, annual Revenue would be $2 millions.

In the Healthcare sector 305 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1642, from total ranking in previous quarter at 2497.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 306
Overall # 1642

Revenue TTM Y/Y Growth Statistics
High Average Low
69.82 %
7.49 %
-41.75 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 217
S&P 500 # 842




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PBIO's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2024
Organon and Co -0.06%$ -0.062 millions
Royalty Pharma Plc-0.17%$ -0.174 millions
Repligen Corp-0.21%$ -0.207 millions
Whitehawk Therapeutics Inc -0.37%$ -0.371 millions
3m Company-0.45%$ -0.446 millions
T2 Biosystems Inc -0.61%$ -0.611 millions
Hcw Biologics Inc -0.63%$ -0.635 millions
Enhabit Inc -0.65%$ -0.648 millions
Sonoma Pharmaceuticals Inc -1.05%$ -1.050 millions
Encision Inc -1.36%$ -1.358 millions
Vaso Corporation-1.40%$ -1.399 millions
Teladoc Health Inc -1.53%$ -1.527 millions
Zimvie Inc -1.55%$ -1.549 millions
Alpha Pro Tech Ltd -1.65%$ -1.645 millions
Novavax inc -2.11%$ -2.107 millions
Agile Therapeutics Inc-2.23%$ -2.232 millions
Fresenius Medical Care Ag-2.33%$ -2.330 millions
Avantor Inc -2.36%$ -2.357 millions
Aspira Women s Health inc -2.81%$ -2.810 millions
Viatris Inc -3.11%$ -3.113 millions
Catheter Precision Inc -3.13%$ -3.125 millions
Nrc Health-3.15%$ -3.153 millions
Akoya Biosciences Inc -3.16%$ -3.158 millions
Neuronetics Inc -3.55%$ -3.547 millions
Mettler toledo International Inc -3.60%$ -3.601 millions
Prestige Consumer Healthcare Inc -4.18%$ -4.181 millions
Dentsply Sirona Inc -4.28%$ -4.280 millions
Waters Corporation-4.33%$ -4.327 millions
Accelerate Diagnostics Inc -4.39%$ -4.394 millions
Envista Holdings Corporation-4.50%$ -4.499 millions


About Pressure Biosciences Inc Revenue Growth Rates (PBIO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pressure Biosciences Inc (CIK 830656).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-25-005468
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pressure Biosciences Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.